Symbols / HQH Stock $18.99 -0.89% Abrdn Healthcare Investors
HQH (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Ratings
Current target
$18.99
Low
—
High
—
Mean
—
News
RSS: Latest HQH news- Hqh stock hits 52-week low at 19.31 USD - Investing.com ue, 02 Jun 2026 13
- Top abrdn Healthcare Investors (HQH) Competitors 2026 - MarketBeat Fri, 29 May 2026 07
- Avoiding Lag: Real-Time Signals in (HQH) Movement - Stock Traders Daily Sun, 24 May 2026 18
- HQH: Growth Potential Limited But Portfolio Structure (NYSE:HQH) - Seeking Alpha Wed, 20 May 2026 07
- 5 Healthcare Dividends Paying Up to 14.1% - Forbes Mon, 23 Mar 2026 07
- This 12% Dividend Is Now On Sale (Thanks to a “Hidden” $30-Billion Move) - Contrarian Outlook hu, 18 Sep 2025 07
- HQH Stock Analysis: abrdn Healthcare Investors 0.38% Dip at $18.21 Performance Outlook - Xã Thanh Hà Fri, 03 Apr 2026 07
- HQH: Strong Returns Fuel Higher Payout, But Valuation Not As Compelling (Downgrade) - Seeking Alpha ue, 03 Mar 2026 08
- Abrdn Healthcare Investors: - marketscreener.com Wed, 20 May 2026 07
- HQH: Severely Underperforms Peers (Rating Downgrade) - Seeking Alpha Sat, 08 Nov 2025 08
- abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce an Additional 20% Increase in Distribution Rates Representing a 50% Increase Since January 2024 - ACCESS Newswire hu, 23 Jan 2025 22
- Abrdn Healthcare Investors stock hits 52-week high at $19.98 By Investing.com - Investing.com ue, 17 Feb 2026 08
- abrdn Healthcare Investors Shares of Beneficial Interest Dividends – NYSE:HQH - TradingView Sat, 15 Apr 2023 07
- 5 ‘Healthy’ Dividends Paying Up to 14.1% - Contrarian Outlook Fri, 20 Mar 2026 07
- Variable Payouts, Permanent Income: Why I’m Buying These 11% Yields Today - Seeking Alpha Wed, 22 Apr 2026 07
Financials
Statement View
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
99.81
-46.47%
|
186.46
+220.82%
|
58.12
+130.23%
|
-192.26
|
| Operating Revenue |
|
99.81
-46.47%
|
186.46
+220.82%
|
58.12
+130.23%
|
-192.26
|
| Operating Expense |
|
1.20
-20.51%
|
1.51
-15.34%
|
1.78
-9.22%
|
1.96
|
| Selling General And Administration |
|
1.14
-21.14%
|
1.45
+17.40%
|
1.24
-11.73%
|
1.40
|
| General And Administrative Expense |
|
1.14
-21.14%
|
1.45
+17.40%
|
1.24
-11.73%
|
1.40
|
| Other Operating Expenses |
|
0.06
-5.03%
|
0.06
-89.28%
|
0.55
-2.97%
|
0.56
|
| Net Income |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Pretax Income |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Net Interest Income |
|
1.00
-50.39%
|
2.02
+225.57%
|
0.62
+452.04%
|
0.11
|
| Interest Income |
|
1.00
-50.39%
|
2.02
+225.57%
|
0.62
+452.04%
|
0.11
|
| Gain On Sale Of Security |
|
26.04
-45.47%
|
47.76
-47.02%
|
90.15
+35.82%
|
66.38
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Net Income From Continuing Operation Net Minority Interest |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Net Income From Continuing And Discontinued Operation |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Net Income Continuous Operations |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Normalized Income |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Net Income Common Stockholders |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Diluted EPS |
|
—
|
3.53
+223.85%
|
1.09
+125.47%
|
-4.28
|
| Basic EPS |
|
—
|
3.53
+223.85%
|
1.09
+125.47%
|
-4.28
|
| Basic Average Shares |
|
—
|
52.39
+1.37%
|
51.68
+13.89%
|
45.38
|
| Diluted Average Shares |
|
—
|
52.39
+1.37%
|
51.68
+13.89%
|
45.38
|
| Diluted NI Availto Com Stockholders |
|
98.61
-46.68%
|
184.95
+228.30%
|
56.33
+129.00%
|
-194.23
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Assets |
|
1,097.26
+3.42%
|
1,060.99
+13.78%
|
932.49
+0.67%
|
926.28
|
| Cash And Cash Equivalents |
|
0.00
+5.36%
|
0.00
-73.83%
|
0.00
-72.98%
|
0.00
|
| Cash Financial |
|
0.00
+5.36%
|
0.00
-73.83%
|
0.00
-72.98%
|
0.00
|
| Receivables |
|
2.54
+412.46%
|
0.50
-92.77%
|
6.85
+139.02%
|
2.87
|
| Taxes Receivable |
|
0.01
+0.00%
|
0.01
|
—
|
—
|
| Prepaid Assets |
|
0.08
-20.19%
|
0.09
+85.83%
|
0.05
+3.46%
|
0.05
|
| Investments And Advances |
|
1,094.63
+3.23%
|
1,060.39
+14.56%
|
925.59
+0.24%
|
923.36
|
| Total Liabilities Net Minority Interest |
|
3.43
+145.78%
|
1.40
+21.45%
|
1.15
-88.17%
|
9.71
|
| Payables |
|
2.11
+121.82%
|
0.95
|
—
|
8.50
|
| Accounts Payable |
|
1.21
|
—
|
—
|
—
|
| Other Payable |
|
0.89
-6.00%
|
0.95
|
—
|
8.50
|
| Stockholders Equity |
|
1,093.83
+3.23%
|
1,059.60
+13.77%
|
931.34
+1.61%
|
916.56
|
| Common Stock Equity |
|
1,093.83
+3.23%
|
1,059.60
+13.77%
|
931.34
+1.61%
|
916.56
|
| Capital Stock |
|
0.56
+6.48%
|
0.52
+5.44%
|
0.49
+4.43%
|
0.47
|
| Common Stock |
|
0.56
+6.48%
|
0.52
+5.44%
|
0.49
+4.43%
|
0.47
|
| Share Issued |
|
55.51
+6.48%
|
52.13
+5.44%
|
49.44
+4.43%
|
47.34
|
| Ordinary Shares Number |
|
55.51
+6.48%
|
52.13
+5.44%
|
49.44
+4.43%
|
47.34
|
| Additional Paid In Capital |
|
991.69
+5.37%
|
941.13
+1.76%
|
924.88
+3.77%
|
891.27
|
| Retained Earnings |
|
101.59
-13.87%
|
117.95
+1875.02%
|
5.97
-75.94%
|
24.82
|
| Total Equity Gross Minority Interest |
|
1,093.83
+3.23%
|
1,059.60
+13.77%
|
931.34
+1.61%
|
916.56
|
| Net Tangible Assets |
|
1,093.83
+3.23%
|
1,059.60
+13.77%
|
931.34
+1.61%
|
916.56
|
| Tangible Book Value |
|
1,093.83
+3.23%
|
1,059.60
+13.77%
|
931.34
+1.61%
|
916.56
|
| Available For Sale Securities |
|
15.61
-54.67%
|
34.43
+5.18%
|
32.74
|
—
|
| Cash Cash Equivalents And Federal Funds Sold |
|
0.00
+5.36%
|
0.00
-73.83%
|
0.00
-72.98%
|
0.00
|
| Derivative Product Liabilities |
|
1.09
+314.45%
|
0.26
|
—
|
—
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
1,079.02
+5.17%
|
1,025.96
+14.91%
|
892.85
-3.30%
|
923.36
|
| Investmentin Financial Assets |
|
1,094.63
+3.23%
|
1,060.39
+14.56%
|
925.59
+0.24%
|
923.36
|
No cash flow data available.
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42024-07-18 View
- 42024-04-12 View
- 42024-01-09 View
- 42024-01-04 View
- 42024-01-02 View
- 42023-09-25 View
- 42023-09-20 View
- 8-K2023-09-12 View
- 42022-03-24 View
- 42022-01-27 View
- 42020-10-26 View
- 42020-10-21 View
- 42020-09-23 View
- 42020-05-22 View
- 42020-03-17 View
- 42018-12-26 View
- 42018-10-25 View
- 42018-10-17 View
- 42018-01-29 View
- 42016-01-07 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|